Protagonist Therapeutics PTGX
NASDAQ PTGX
$139.53 +1.45 (+1.05%)
At close: Oct 22, 2026 · 4:00 PM EDT

Protagonist Therapeutics (PTGX) Short-term Investments (2015 - 2026)

Updated

Protagonist Therapeutics' Short-term Investments came in at $362.5 million for Q2 2026, down 9.8% from $401.92 million a year earlier but up 2.4% from the prior quarter.

Analysis

Protagonist Therapeutics (PTGX) Short-term Investments (2015 - 2026) Analysis & Trends

At the end of FY2025, Protagonist Therapeutics' Short-term Investments was $439 million, up 36.5% from FY2024.

  • Short-term Investments has increased in each of the last three years, with a five-year compound annual growth rate of 18.4% (FY2020 to FY2025).
  • Going back by year, Short-term Investments was $321.7 million in FY2024 (+107.7%), $154.9 million in FY2023 (+38.8%), $111.61 million in FY2022 (-45.1%) and $203.24 million in FY2021 (+7.8%).
  • The five-year range for quarterly Short-term Investments is $78.02 million (Q2 2023) to $462.4 million (Q3 2025).
  • Year-over-year, Short-term Investments increased in six of the last eight quarters, with growth averaging 88.7%.
  • The fastest year-over-year change in Short-term Investments over five years came in Q3 2024 (growth of 274.2%), and the weakest in Q2 2023 (a decline of 54.6%).
  • Business Quant data shows PTGX's Short-term Investments at $354.1 million (Q1 2026), $439 million (Q4 2025) and $462.4 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,230.11 Bn 1,198.70 Bn 19.71 Bn
2 Johnson & Johnson 644.39 Bn 564.25 Bn 17.30 Bn
3 AbbVie 503.52 Bn 476.68 Bn 12.70 Bn
4 Merck 363.29 Bn 317.72 Bn 12.21 Bn
5 Novartis Ag 298.23 Bn 262.62 Bn 11.24 Bn
6 Astrazeneca 267.53 Bn 241.29 Bn 12.86 Bn
7 Amgen 241.80 Bn 197.20 Bn 7.24 Bn
8 Gilead Sciences 195.07 Bn 169.19 Bn 6.22 Bn
9 Pfizer 173.33 Bn 120.28 Bn 10.94 Bn
10 Protagonist Therapeutics 9.02 Bn 6.55 Bn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 362.50 Mn
Mar 31, 2026 354.10 Mn
Dec 31, 2025 439.00 Mn
Sep 30, 2025 462.40 Mn
Jun 30, 2025 401.92 Mn
Mar 31, 2025 434.71 Mn
Dec 31, 2024 321.70 Mn
Sep 30, 2024 337.60 Mn
Jun 30, 2024 208.40 Mn
Mar 31, 2024 150.10 Mn
Dec 31, 2023 154.90 Mn
Sep 30, 2023 90.22 Mn
Jun 30, 2023 78.02 Mn
Mar 31, 2023 103.10 Mn
Dec 31, 2022 111.61 Mn
Sep 30, 2022 114.62 Mn
Jun 30, 2022 171.70 Mn
Mar 31, 2022 206.81 Mn
Dec 31, 2021 203.24 Mn
Sep 30, 2021 193.80 Mn
API Access

Protagonist Therapeutics Short-term Investments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=short-term-investments&ticker=PTGX&period=max&api_key=YOUR_API_KEY